Haider Saleh, Hassan Md Zakiul
Infectious Disease Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Infectious Disease Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
BMJ Glob Health. 2025 Feb 12;10(2):e017271. doi: 10.1136/bmjgh-2024-017271.
The WHO South-East Asia Region (SEAR), with its high population density, is recognised by epidemiologists as a critical reservoir for the emergence and global dissemination of novel influenza strains, making it a potential epicentre for future influenza pandemics. Despite this significant risk, most SEAR countries lack comprehensive seasonal influenza vaccination policies, resulting in low vaccine uptake across the region. This review analysed the latest WHO National Influenza Programme factsheets from the 11 SEAR member states and supplemented this with extensive manual literature searches using electronic databases and government websites. As of October 2022, only three countries-India, Bhutan and Thailand-had established seasonal influenza vaccination policies. Among them, Bhutan and Thailand have policies that cover all five WHO-recommended high-risk groups. While national influenza surveillance systems are in place across SEAR, only India and the Democratic People's Republic of Korea claim full population coverage. Influenza vaccine production capacity is limited to Bangladesh, India and Indonesia. The region's varied climatic conditions and insufficient local data have further obscured the true burden of influenza. Thailand offers a successful model for other countries in the region, beginning with the most vulnerable groups and gradually expanding coverage. To effectively develop and implement national influenza vaccination policies, SEAR countries must close the evidence gap by strengthening surveillance systems to provide accurate, timely data and prioritise context-specific research, leverage existing vaccine infrastructure, enhance public education and finally engage with local and international stakeholders to establish strong international cooperation to support these efforts and improve pandemic preparedness.
世界卫生组织东南亚区域(SEAR)人口密度高,流行病学家认为该区域是新型流感毒株出现和全球传播的关键储存库,使其成为未来流感大流行的潜在震中。尽管存在这种重大风险,但大多数东南亚区域国家缺乏全面的季节性流感疫苗接种政策,导致该区域疫苗接种率较低。本综述分析了世界卫生组织提供的东南亚区域11个成员国的最新国家流感规划情况说明书,并通过使用电子数据库和政府网站进行广泛的人工文献检索对其进行补充。截至2022年10月,只有印度、不丹和泰国这三个国家制定了季节性流感疫苗接种政策。其中,不丹和泰国的政策覆盖了世界卫生组织推荐的所有五个高危群体。虽然东南亚区域各国都建立了国家流感监测系统,但只有印度和朝鲜声称实现了全民覆盖。流感疫苗生产能力仅限于孟加拉国、印度和印度尼西亚。该区域多样的气候条件和当地数据不足进一步掩盖了流感的真实负担。泰国为该区域其他国家提供了一个成功模式,从最脆弱群体开始,逐步扩大覆盖范围。为了有效制定和实施国家流感疫苗接种政策,东南亚区域国家必须通过加强监测系统以提供准确、及时的数据来缩小证据差距,优先开展针对具体情况的研究,利用现有的疫苗基础设施,加强公众教育,最后与地方和国际利益攸关方合作,建立强有力的国际合作以支持这些努力并提高大流行防范能力。